{"title":"收回:IL2RB是一种与泛癌免疫渗透相关的预后生物标志物。","authors":"Journal Of Oncology","doi":"10.1155/2023/9807856","DOIUrl":null,"url":null,"abstract":"<p><p>[This retracts the article DOI: 10.1155/2022/2043880.].</p>","PeriodicalId":16619,"journal":{"name":"Journal of Oncology","volume":"2023 ","pages":"9807856"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632053/pdf/","citationCount":"0","resultStr":"{\"title\":\"Retracted: IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer.\",\"authors\":\"Journal Of Oncology\",\"doi\":\"10.1155/2023/9807856\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>[This retracts the article DOI: 10.1155/2022/2043880.].</p>\",\"PeriodicalId\":16619,\"journal\":{\"name\":\"Journal of Oncology\",\"volume\":\"2023 \",\"pages\":\"9807856\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632053/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1155/2023/9807856\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2023/9807856","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
期刊介绍:
Journal of Oncology is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to breast cancer, lung cancer, gastrointestinal cancer, skin cancer, head and neck cancer, paediatric oncology, neurooncology as well as genitourinary cancer. The journal provides a multidisciplinary forum for translational and clinical oncology research in the areas of molecular pathology, genomics, diagnosis and therapy, with a specific focus on molecular targeted agents and novel immune therapies.